Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding

Ghadimi, 2016, Andexanet alfa for the reversal of factor Xa inhibitor related anticoagulation, Expert Rev Hematol, 9, 115, 10.1586/17474086.2016.1135046 Siegal, 2015, Andexanet alfa for the reversal of factor Xa inhibitor activity, N Engl J Med, 373, 2413, 10.1056/NEJMoa1510991 Connolly, 2016, Andexanet alfa for acute major bleeding associated with factor Xa inhibitors, N Engl J Med, 375, 1131, 10.1056/NEJMoa1607887 Connolly, 2019, Full study report of Andexanet alfa for bleeding associated with factor Xa inhibitors, N Engl J Med, 380, 1326, 10.1056/NEJMoa1814051 Brown, 2019, Real-world utilization of andexanet alfa, Am J Emerg Med Abraham, 2022, Management of Patients on anticoagulants and Antiplatelets during acute gastrointestinal bleeding and the Peri-endoscopic period: a clinical practice guideline dissemination tool, Am J Gastroenterol, 117, 513, 10.14309/ajg.0000000000001627 Von Elm, 2008, The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting of observational studies, Notfall und Rettungsmedizin, 11, 260, 10.1007/s10049-008-1057-1 Schulman, 2010, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients, J Thromb Haemost, 8, 202, 10.1111/j.1538-7836.2009.03678.x Kaatz, 2015, Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH, J Thromb Haemost, 13, 2119, 10.1111/jth.13140 Thygesen, 2018, Fourth universal definition of myocardial infarction (2018), J Am Coll Cardiol, 72, 2231, 10.1016/j.jacc.2018.08.1038 Kleindorfer, 2021, Guideline for the prevention of stroke in patients with stroke and transient ischemic attack Criqui, 2021, Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association, Circulation, E171 Saltzman, 2011, ORIGINAL ARTICLE : clinical endoscopy a simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding, YMGE, 74, 1215 Thandassery, 2015, Clinical application of AIMS65 scores to predict outcomes in patients with upper gastrointestinal hemorrhage, Clin Endosc, 48, 380, 10.5946/ce.2015.48.5.380 Rockall, 1996, Risk assessment after acute upper gastrointestinal haemorrhage, Gut, 38, 316, 10.1136/gut.38.3.316 Vreeburg, 1999, Validation of the Rockall risk scoring system in upper gastrointestinal bleeding, Gut, 44, 331, 10.1136/gut.44.3.331 Blatchford, 2000, A risk score to predict need for treatment for upper-gastrointestinal haemorrhage, Lancet, 356, 1318, 10.1016/S0140-6736(00)02816-6 Laursen, 2021, ABC score: a new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: an international multicentre study, Gut, 70, 707, 10.1136/gutjnl-2019-320002 Saade, 2022, Validation of the new ABC score for predicting 30-day mortality in gastrointestinal bleeding, BMC Gastroenterol, 22, 1, 10.1186/s12876-022-02374-y Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Friberg, 2012, Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study, Eur Heart J, 33, 1500, 10.1093/eurheartj/ehr488 Ntaios, 2013, Long-term stroke outcome in patients without atrial fibrillation, Neurology, 80, 1009, 10.1212/WNL.0b013e318287281b Gu, 2020, Risk of major gastrointestinal bleeding with new vs conventional Oral anticoagulants: a systematic review and Meta-analysis, Clin Gastroenterol Hepatol, 18, 792, 10.1016/j.cgh.2019.05.056 Radaelli, 2015, Management of anticoagulation in patients with acute gastrointestinal bleeding, Dig Liver Dis, 47, 621, 10.1016/j.dld.2015.03.029 Yao, 2016, Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation, J Am Heart Assoc, 5, 1, 10.1161/JAHA.116.003725 Lip, 2021, Oral anticoagulants for Nonvalvular atrial fibrillation in patients with high risk of gastrointestinal bleeding, JAMA Netw Open, 4, 1, 10.1001/jamanetworkopen.2021.20064 Guo, 2019, Differences in gastrointestinal safety profiles among novel oral anticoagulants: evidence from a network meta-analysis, Clin Epidemiol, 11, 911, 10.2147/CLEP.S219335 Smith, 2016, Selecting, adapting, and implementing evidencebased interventions in rural settings: an analysis of 70 community examples, J Health Care Poor Underserved, 27, 181, 10.1353/hpu.2016.0179 Nederpelt, 2020, Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa, J Thromb Haemost, 18, 2532, 10.1111/jth.15031 Xu, 2021, Anticoagulant-associated gastrointestinal bleeding: framework for decisions about whether, when and how to resume anticoagulants, J Thromb Haemost, 19, 2383, 10.1111/jth.15466 Cohen, 2022, Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleeding, JACEP Open, 3, 10.1002/emp2.12655 Nederpelt, 2021, Andexanet alfa or prothrombin complex concentrate for factor Xa inhibitor reversal in acute major bleeding: a systematic review and Meta-analysis, Crit Care Med, E1025, 10.1097/CCM.0000000000005059 Zhang, 2019, The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis, Med, 98